BioMarin Pharmaceutical Market Cap

BioMarin Pharmaceutical has a market cap or net worth of €9.44 billion as of August 15, 2025. Its market cap has decreased by -36.23% in one year.

Market Cap

9.44B

Enterprise Value

8.73B

Revenue

2.61B

Ranking

n/a

PE Ratio

16.86

Stock Price

€49.63

Market Cap Chart

Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 425.62M to 9.44B, an increase of 2,116.87%. That is a compound annual growth rate of 12.61%.

Market Cap History

Date	Market Cap	% Change
Aug 15, 2025	9.44B	-22.02%
Dec 31, 2024	12.10B	-26.36%
Dec 29, 2023	16.43B	-8.70%
Dec 30, 2022	18.00B	26.18%
Dec 31, 2021	14.26B	9.60%
Dec 31, 2020	13.01B	-3.84%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
UniCredit	107.40B
Intesa Sanpaolo	97.13B
Enel SpA	81.43B
Ferrari	70.84B
Assicurazioni Generali	51.89B
Eni S.p.A.	45.41B
Leonardo S.p.a.	27.55B
Poste Italiane	26.13B

Market Cap Rankings